BillionToOne, Inc.: shareholders and insiders

BLLNNASDAQHealthcare · Services-Medical Laboratories

Price

$91.54

November 18, 2026Market cap $4.3B

What Ploutos Investor adds for BillionToOne

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 3 fiscal years, from 2023
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Notes on these figures

  • Earnings per share here are the last twelve months' earnings over today's shares, so they agree with the P/E. The number of shares changed a lot during the year, so they differ from the earnings per share the company filed, which use the year's average number of shares.

Insiders and their shares

Purchases and sales by officers and directors from Nov 19, 2025 to Nov 12, 2026, from their own Form 4 filings.

53 Form 4s

Bought on the market

–

nobody

Sold on the market

$58M

6 people

From Nov 19, 2025 to Nov 19, 2026, the days the chart shows. Change its range and the figures follow.

How the sales were made, as a share of their value

  • Under a set plan100%
  • The rest0%

By year

Insiders' open-market purchases (up) and sales (down), by value, since Nov 19, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.

2026·no buys·sold $55M by 6 people

  • 2025: no buys, no sales
  • 2026: no buys, sold $55M by 6 people
  • Nov 9, 2026Krishna Kittu KolluriDirector
    Kind
  • Nov 9, 2026Krishna Kittu KolluriDirector
    Kind
  • Nov 9, 2026Krishna Kittu KolluriDirector
    Kind
  • Nov 9, 2026Krishna Kittu KolluriDirector
    Kind
  • Nov 9, 2026Krishna Kittu KolluriDirector
    Kind
  • Nov 9, 2026Krishna Kittu KolluriDirector
    Kind
  • Nov 9, 2026Krishna Kittu KolluriDirector
    Kind
  • Nov 9, 2026Krishna Kittu KolluriDirector
    Kind
  • Nov 9, 2026Krishna Kittu KolluriDirector
    Kind
  • Nov 9, 2026Krishna Kittu KolluriDirector
    Kind
  • Nov 9, 2026Krishna Kittu KolluriDirector
    Kind
  • Nov 9, 2026Krishna Kittu KolluriDirector
    Kind
  • Nov 9, 2026Krishna Kittu KolluriDirector
    Kind
  • Nov 9, 2026Krishna Kittu KolluriDirector
    Kind
  • Nov 9, 2026Krishna Kittu KolluriDirector
    Kind
  • Nov 9, 2026Krishna Kittu KolluriDirector
    Kind
  • Nov 6, 2026Firat IleriDirector
    Kind
  • Nov 2, 2026Bosch John Roderick tenSVP of Laboratory Operations
    Kind10b5-1
  • Nov 2, 2026Bosch John Roderick tenSVP of Laboratory Operations
    Kind10b5-1
  • Nov 2, 2026Oguzhan AtayChairman and CEO
    Kind10b5-1
  • Nov 2, 2026Oguzhan AtayChairman and CEO
    Kind10b5-1
  • Nov 2, 2026Oguzhan AtayChairman and CEO
    Kind10b5-1
  • Nov 2, 2026Oguzhan AtayChairman and CEO
    Kind10b5-1
  • Nov 2, 2026Oguzhan AtayChairman and CEO
    Kind10b5-1
  • Nov 2, 2026Oguzhan AtayChairman and CEO
    Kind10b5-1

From the Form 4s insiders file with the SEC within two business days of each trade.

Insiders and their shares

Every buy and sale by BLLN's officers and directors from 2025 up to November 18, 2025, 1 more calendar year

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 2 years.

Major holders (over 5%)

Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.

4 Holders over 5%1 On a 13DNov 9, 2026 Latest filing
  • Hummingbird Ventures Management NVwith 9 more personsClass A common stock
    Share of class18.6%
  • NeoTribe Ventures I, L.P. ("NTV I")with 7 more personsClass A Common Stock, par value $0.00001 per share
    Share of class10.6%
  • Oguzhan AtayClass A common stock, par value $0.00001 per share
    Share of class7.30%
  • David TsaoClass A common stock, par value $0.00001 per share
    Share of class6.90%

What the holders on a 13D state as their purpose

From Item 4 of the filing, in the holder's own words. It is the intention the holder states, not something that happened.

  • Hummingbird Ventures Management NV18.6%From the filing of Jan 20, 2026

    The Shares reported herein as being beneficially owned by the Reporting Persons were acquired for investment purposes. The Reporting Persons acquired beneficial ownership of the shares as described in this Schedule 13D for investment purposes and intend to review their investment in the Issuer on a continuing basis. Depending on various factors, including but not limited to the Issuer's business, prospects, financial position and strategic direction, price levels of the shares, conditions in the securities markets, and general economic and industry conditions, each Reporting Person may in the future take such actions with respect to its investment in the Issuer as it deems appropriate,…

    From the filing of Jan 20, 2026

From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.

Well-known managers

Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.

Sep 30, 2026 quarter end
  • Millennium Mgmt (Englander)
    In the quarter
  • Renaissance Technologies
    In the quarter+90%
  • Citadel Advisors (Griffin)
    In the quarter
  • D.E. Shaw
    In the quarter+573%

From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).

Short interest

How many of the company's shares have been sold borrowed and not yet bought back, twice a month.

On Oct 15, 2026, 6.20% of its shares outstanding were held short, +4.0% since the report before.

Shares held short
2.93M
6.20%
Since the report before2.82M on Sep 30, 2026
+4.0%
5.5
530.7K
More days to cover thanof 4,578 US-listed companies with enough volume
66%
Report date
Oct 15, 2026
  • Nov 14, 2025: Shares held short 54.7K
  • Nov 28, 2025: Shares held short 175.7K
  • Dec 15, 2025: Shares held short 315.3K
  • Dec 31, 2025: Shares held short 592.8K
  • Jan 15, 2026: Shares held short 712.2K
  • Jan 30, 2026: Shares held short 922.9K
  • Feb 13, 2026: Shares held short 988.8K
  • Feb 27, 2026: Shares held short 1.17M
  • Mar 13, 2026: Shares held short 1.31M
  • Mar 31, 2026: Shares held short 1.64M
  • Apr 15, 2026: Shares held short 1.94M
  • Apr 30, 2026: Shares held short 2.30M
  • May 15, 2026: Shares held short 1.47M
  • May 29, 2026: Shares held short 1.68M
  • Jun 15, 2026: Shares held short 1.81M
  • Jun 30, 2026: Shares held short 2.42M
  • Jul 15, 2026: Shares held short 2.41M
  • Jul 31, 2026: Shares held short 1.92M
  • Aug 14, 2026: Shares held short 1.95M
  • Aug 31, 2026: Shares held short 2.35M
  • Sep 15, 2026: Shares held short 2.63M
  • Sep 30, 2026: Shares held short 2.82M
  • Oct 15, 2026: Shares held short 2.93M

As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.

Short sales in daily trading70.3% of the shares in the last 14 sessions' reported trades were short sales.

In the last 14 sessions, 70.3% of the shares in the reported trades were short sales, against 55.8% in the 14 before.

Last 14 sessionsOct 30, 2026 – Nov 18, 2026
70.3%
The 14 beforeOct 12, 2026 – Oct 29, 2026
55.8%
Change
+14.5 pts
Short sales a dayon average, of 401.1K shares
282.2K
More than atof 3,656 US-listed companies, same days
98%
Median of alleight in ten from 34.4% to 63.7%
50.3%
  • Oct 12, 2026: Short sales 40.9%
  • Oct 13, 2026: Short sales 52.3%
  • Oct 14, 2026: Short sales 58.3%
  • Oct 15, 2026: Short sales 50.4%
  • Oct 16, 2026: Short sales 64.7%
  • Oct 19, 2026: Short sales 60.2%
  • Oct 20, 2026: Short sales 72.9%
  • Oct 21, 2026: Short sales 63.5%
  • Oct 22, 2026: Short sales 65.6%
  • Oct 23, 2026: Short sales 72.4%
  • Oct 26, 2026: Short sales 73.4%
  • Oct 27, 2026: Short sales 48.5%
  • Oct 28, 2026: Short sales 43.8%
  • Oct 29, 2026: Short sales 35.1%
  • Oct 30, 2026: Short sales 59.1%
  • Nov 2, 2026: Short sales 68.5%
  • Nov 3, 2026: Short sales 70.8%
  • Nov 4, 2026: Short sales 59.5%
  • Nov 5, 2026: Short sales 82.9%
  • Nov 6, 2026: Short sales 83.6%
  • Nov 9, 2026: Short sales 65.6%
  • Nov 10, 2026: Short sales 63.6%
  • Nov 11, 2026: Short sales 69.6%
  • Nov 12, 2026: Short sales 80.6%
  • Nov 13, 2026: Short sales 87.3%
  • Nov 16, 2026: Short sales 57%
  • Nov 17, 2026: Short sales 68.3%
  • Nov 18, 2026: Short sales 58.5%

This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.

What the insiders hold

The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.

6.65M Insiders' shares
  • NeoTribe Ventures I, L.P.
    Directly3.49M
  • Krishna Kittu KolluriDirector
    Directly2.72M
  • Shan Riku SakakibaraChief Product Officer
    Directly196.5K
  • Oguzhan AtayChairman and CEO
    Directly141.2K
  • Firat IleriDirector
    Directly39.9K
  • Bosch John Roderick tenSVP of Laboratory Operations
    Directly16.6K
  • Akshay RaiDirector
    Directly14.0K
  • Thomas S BremnerDirector
    Directly11.4K
  • Thomas P. LynchGeneral Counsel, Chief Compliance Officer and Secretary
    Directly10.7K
  • Anthony PaganoDirector
    Directly7,913
  • Nancy JoAnn JohnsonSenior Vice President of Sales and Commercial Operations
    Directly6,900
  • David TsaoChief Technology Officer
    Directly1,000

A lower bound: it counts only the 12 officers and directors with a market trade since Nov 20, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.

The ETFs that hold it

Which of the 345 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.

8 ETFs holding it0.04% The largest weight (VBK)
  • VBKVanguard Small-Cap Growth Index Fund
    Weight in the fund0.04%
  • VBVanguard Small-Cap Index Fund
    Weight in the fund0.03%
  • VBRVanguard Small-Cap Value Index Fund
    Weight in the fund0.03%
  • ONEQFidelity Nasdaq Composite Index ETF
    Weight in the fund0.01%
  • SCHASchwab U.S. Small-Cap ETF
    Weight in the fund0.01%
  • VXFVanguard Extended Market Index Fund
    Weight in the fund0.01%
  • VTIVanguard Total Stock Market Index Fund
    Weight in the fund0.00%
  • SCHBSchwab U.S. Broad Market ETF
    Weight in the fund0.00%

8 of the 345 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.

Institutional investors by quarter

Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.

156 Managers, Q2 2026$1.8B Value of their positions
  • Q4 2025: Managers 90
  • Q1 2026: Managers 91
  • Q2 2026: Managers 156

Q2 2026: 156 managers held 15.28M shares, worth $1.8B. During the quarter 77 opened a position, 12 closed one, 47 added and 13 trimmed.

The largest holders, Q2 2026

  • Adams Street Partners
    In the quarter
  • Price T Rowe Associates
    In the quarter+37%
  • Baillie Gifford
    In the quarter-28%
  • Vanguard Portfolio Management
    In the quarter+456%
  • Invesco
    In the quarter+106%
  • Vanguard Capital Management
    In the quarter+338%
  • Neuberger Berman Group
    In the quarter+7.8%
  • Bamco
    In the quarter
  • Wasatch Advisors
    In the quarter+40%
  • Millennium Mgmt (Englander)
    In the quarter

From the SEC's Form 13F data sets, Q4 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.

Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.

The full analysis

What do BillionToOne's filings show?

Who buys and sells is one part of BillionToOne's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about BLLN's shareholders

Didn't find what you were looking for?

Ask us
Have BLLN's insiders bought or sold?

From Jun 10, 2026 to Nov 12, 2026 BillionToOne's insiders bought 0 and sold $58M of shares on the market. 100% of the sales were under set 10b5-1 plans.

Which well-known managers hold BLLN?

4 of the managers we track held the shares on Sep 30, 2026. The largest position was Millennium Mgmt (Englander)'s, worth $51M.

Is every insider transaction a purchase or a sale?

No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.